The Patent Finder

Viventia Biotech Inc.

Also on record
Records under this name other than patents Viventia Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Viventia Biotech Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,946,390Novel Cancer-Associated Antigen
Formerly held
In force
 · Low confidence
In forceLow confidence
US 7,956,162Cancer-associated antigen
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,084,576Cancer associated glucose transporter 8 variant
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,697,075Cancer specific antibody and cell surface proteins
Formerly held
Term ended
Term ended Dec 21, 2025 · USPTO record
Term endedTerm ended Dec 21, 2025USPTO record
US 8,716,234Cytotoxins Comprising Modified Bouganin Toxin for the Treatment of Cancer
Held by another company
Term ended
Term ended Dec 15, 2025 · High confidence
Term endedTerm ended Dec 15, 2025High confidence
US 8,545,840Methods for treating cancer using an immunotoxin
Formerly held
Term ended
Term ended Jun 24, 2025 · USPTO record
Term endedTerm ended Jun 24, 2025USPTO record
US 7,339,031Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
Formerly held
Term ended
Term ended Jun 23, 2025 · High confidence
Term endedTerm ended Jun 23, 2025High confidence
US 8,969,540Tumor Specific Antibody
Formerly held
Term ended
Term ended Jun 10, 2025 · Medium confidence
Term endedTerm ended Jun 10, 2025Medium confidence
US 7,750,136Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
Formerly held
Term ended
Term ended May 8, 2025 · High confidence
Term endedTerm ended May 8, 2025High confidence
US 8,389,286Cancer-associated antigen
Formerly held
Lapsed on the fee record
Ended Mar 5, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 5, 2025USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited